Literature DB >> 11239724

Relapse outcomes in a randomized trial of residential and day drug abuse treatment.

G L Greenwood1, W J Woods, J Guydish, E Bein.   

Abstract

Relapse outcomes at 6-, 12-, and 18-month intervals were compared between clients randomly assigned to day (n=114) versus residential (n=147) drug abuse treatment. Day clients were more likely than residential clients to relapse 6 months post-admission (OR=3.06, p<0.001); however, no setting differences at 12 or 18 months were found. Few baseline predictors were prospectively related to relapse at 12 and 18 months. These predictors were usual employment status (part-time OR=17.47, p<0.001; full-time OR=2.54, p<0.001), history of drug injecting (OR=5.39, p<0.01), multiple sex partners (OR=1.16, p<0.01), and not having a gay sexual partner (OR=0.05, p<0.03) during 6 months prior to admission. Still, these baseline predictors, together with the existing literature, could be used by drug treatment professionals to identify individuals who may be at high risk for relapse over time, and to offer specialized treatment and aftercare resources as intervention and prevention measures.

Mesh:

Year:  2001        PMID: 11239724     DOI: 10.1016/s0740-5472(00)00147-1

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  13 in total

Review 1.  Substance use in lesbian, gay, and bisexual populations: an update on empirical research and implications for treatment.

Authors:  Kelly E Green; Brian A Feinstein
Journal:  Psychol Addict Behav       Date:  2011-11-07

2.  Addressing the challenges and opportunities for today's youth: toward an integrative model and its implications for research and intervention.

Authors:  Seth J Schwartz; Hilda Pantin; J Douglas Coatsworth; José Szapocznik
Journal:  J Prim Prev       Date:  2007-03-01

3.  Self-efficacy and social networks after treatment for alcohol or drug dependence and major depression: disentangling person and time-level effects.

Authors:  Matthew J Worley; Ryan S Trim; Susan R Tate; Scott C Roesch; Mark G Myers; Sandra A Brown
Journal:  Psychol Addict Behav       Date:  2014-10-27

4.  Client-Provider relationship in comprehensive substance abuse treatment: differences in residential and nonresidential settings.

Authors:  Hee-Choon Shin; Jeanne C Marsh; Dingcai Cao; Christina M Andrews
Journal:  J Subst Abuse Treat       Date:  2011-08-25

Review 5.  Predicting treatment outcome in stimulant dependence.

Authors:  Martina Reske; Martin P Paulus
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

6.  Modafinil and sleep architecture in an inpatient-outpatient treatment study of cocaine dependence.

Authors:  Peter T Morgan; Gustavo A Angarita; Sofija Canavan; Brian Pittman; Lindsay Oberleitner; Robert T Malison; Vahid Mohsenin; Sarah Hodges; Caroline Easton; Sherry McKee; Andrew Bessette; Erica Forselius
Journal:  Drug Alcohol Depend       Date:  2016-01-08       Impact factor: 4.492

7.  Challenges and Rewards of Conducting Research on Recovery Residences for Alcohol and Drug Disorders.

Authors:  Douglas L Polcin; Amy Mericle; Sarah Callahan; Ronald Harvey; Leonard A Jason
Journal:  J Drug Issues       Date:  2016-01-01

8.  Act Healthy: A Randomized Clinical Trial Evaluating a Behavioral Activation Intervention to Address Substance Use and Medication Adherence Among Low-Income, Black/African American Individuals Living with HIV/AIDS.

Authors:  Jessica F Magidson; Jennifer M Belus; C J Seitz-Brown; Hannah Tralka; Steven A Safren; Stacey B Daughters
Journal:  AIDS Behav       Date:  2021-06-26

Review 9.  Therapeutic communities for addictions: a review of their effectiveness from a recovery-oriented perspective.

Authors:  Wouter Vanderplasschen; Kathy Colpaert; Mieke Autrique; Richard Charles Rapp; Steve Pearce; Eric Broekaert; Stijn Vandevelde
Journal:  ScientificWorldJournal       Date:  2013-01-15

10.  Survival Analysis of Drug Abuse Relapse in Addiction Treatment Centers.

Authors:  Aziz Kassani; Mohsen Niazi; Jafar Hassanzadeh; Rostam Menati
Journal:  Int J High Risk Behav Addict       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.